Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Jöerg Czekalla, MD
JCP
Original Research
Association of Subjective Well-Being, Symptoms, and Side Effects With Compliance After 12 Months of Treatment in Schizophrenia
January 15, 2007
Anne Karow
,
Jöerg Czekalla
,
Ralf W. Dittmann
, et al
JCP
Original Research
Prediction of Remission as a Combination of Symptomatic and Functional Remission and Adequate Subjective Well-Being in 2960 Patients With Schizophrenia
November 15, 2006
Martin Lambert
,
Benno G. Schimmelmann
,
Dieter Naber
, et al
JCP
Original Research
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis
March 1, 2001
Jöerg Czekalla
,
Charles M. Beasley, Jr.
,
Mary Anne Dellva
, et al
JCP
Article
Cardiac Safety Parameters of Olanzapine: Comparison With Other Atypical and Typical Antipsychotics
February 1, 2001
Jöerg Czekalla
,
Sara Kollack-Walker
,
Charles M. Beasley, Jr.
